hypoglycemic agents


Also found in: Dictionary, Thesaurus, Encyclopedia.

hypoglycemic agents (hī´pōglīsē´-mik),

n.pl a large heterogeneous group of drugs prescribed to decrease or control the amount of glucose circulating in the blood; used in the prevention and treatment of diabetes.
References in periodicals archive ?
We focused the main study on utilization of oral hypoglycemic agents (OHAs) used to maintain glycemic control in the treatment of type 2 diabetes.
All 276 patients were using various hypoglycemic agents namely, metformin, acarbose, sulfonylureas, insulin therapy.
Therefore, health care professionals should always be conscious on the possibilities of intake with the prescribed hypoglycemic agents and be able to offer evidence-based explanation particularly on the safety matters on its ingestion.
Typically, however, patients with GCK MODY are treated--inappropriately--with insulin or oral hypoglycemic agents because they have been misdiagnosed as having type 2 or less commonly type 1 diabetes.
Four patients did not know of their diabetic status and four were on insulin therapy whereas all others were on oral hypoglycemic agents.
double dagger]) Oral hypoglycemic agents included [alpha]-glucosidase inhibitors, biguanides, glinides, glitazones, sulfonylureas, and thiazolidinediones.
Olive leaf extract as a hypoglycemic agent in both human diabetic subjects and in rats.
A study in the November 24, 2011 issue of the New England Journal of Medicine JNJEJM) found that four medications or medication classes--warfarin (Coumadin), insulin, antiplatelet agents such as clopidogrel (Plavix) and aspirin, and oral hypoglycemic agents that lower blood glucose levels--were implicated in 67 percent of hospitalizations among American seniors due to adverse drug events.
Whitehurst Professor of Medicine and professor of physiology "The data so far suggest that if both mom and the fetus have a GCK mutation, you may want to forego treatment [with oral hypoglycemic agents or insulin], and even put mom on a high-carb diet, because the baby needs a high glucose level.
Hence, the influence of pioglitazone on body weight and body mass index (BMI) of patients was investigated, by comparing its monotherapy and combination therapies with other hypoglycemic agents commonly prescribed; and also by comparing between different pioglitazone doses within each of the regimen.
The FDA will soon begin to actively monitor the data, seeking answers to specific questions about the performance of medical products, such as the frequency of myocardial infarction among users of oral hypoglycemic agents," they wrote in the New England Journal of Medicine.
OBJECTIVE: To evaluate whether use of oral hypoglycemic agents is associated with an altered breast cancer risk in women.